The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19

被引:0
|
作者
Scavello, Francesco [1 ]
Brunetta, Enrico [2 ]
Mapelli, Sarah N. [1 ]
Nappi, Emanuele [1 ,3 ]
Martin, Ian David Garcia [3 ]
Sironi, Marina [1 ]
Leone, Roberto [1 ]
Solano, Simone [1 ]
Angelotti, Giovanni [4 ]
Supino, Domenico [1 ]
Carnevale, Silvia [1 ]
Zhong, Hang [1 ,3 ]
Magrini, Elena [1 ]
Stravalaci, Matteo [1 ]
Protti, Alessandro [3 ,5 ]
Santini, Alessandro [3 ,5 ]
Costantini, Elena [5 ]
Savevski, Victor [4 ]
Voza, Antonio [3 ,6 ]
Bottazzi, Barbara [1 ]
Bartoletti, Michele [2 ,3 ]
Cecconi, Maurizio [3 ,5 ]
Mantovani, Alberto [1 ,3 ,7 ]
Morelli, Paola [2 ]
Tordato, Federica [2 ]
Garlanda, Cecilia [1 ,3 ]
机构
[1] IRCCS Humanitas Res Hosp, via Manzoni 56, I-20089 Milan, Italy
[2] IRCCS Humanitas Res Hosp, Hosp Hlth Direct, Infect Dis Unit, I-20089 Milan, Italy
[3] Humanitas Univ, Dept Biomed Sci, I-20072 Milan, Italy
[4] IRCCS Humanitas Res Hosp, Artificial Intelligence Ctr, I-20089 Milan, Italy
[5] IRCCS Humanitas Res Hosp, Dept Anesthesia & Intens Care, I-20089 Milan, Italy
[6] IRCCS Humanitas Res Hosp, Emergency Dept, I-20089 Milan, Italy
[7] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England
来源
EBIOMEDICINE | 2024年 / 105卷
关键词
PTX3; COVID-19; Biomarker; Community-acquired infections; Hospital-acquired infections; PATTERN-RECOGNITION MOLECULE; HUMORAL INNATE IMMUNITY; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; BACTERIAL; PROCALCITONIN; SARS-COV-2; INFECTION; DISEASE; COHORT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background COVID-19 clinical course is highly variable and secondary infections contribute to COVID-19 complexity. Early detection of secondary infections is clinically relevant for patient outcome. Procalcitonin (PCT) and C-reactive protein (CRP) are the most used biomarkers of infections. Pentraxin 3 (PTX3) is an acute phase protein with promising performance as early biomarker in infections. In patients with COVID-19, PTX3 plasma concentrations at hospital admission are independent predictor of poor outcome. In this study, we assessed whether PTX3 contributes to early identification fi cation of co-infections during the course of COVID-19. Methods We analyzed PTX3 levels in patients affected by COVID-19 with (n =101) or without (n =179) community or hospital-acquired fungal or bacterial secondary infections (CAIs or HAIs). Findings PTX3 plasma concentrations at diagnosis of CAI or HAI were significantly fi cantly higher than those in patients without secondary infections. Compared to PCT and CRP, the increase of PTX3 plasma levels was associated with the highest hazard ratio for CAIs and HAIs (aHR 11.68 and 24.90). In multivariable Cox regression analysis, PTX3 was also the most significant fi cant predictor of 28-days mortality or intensive care unit admission of patients with potential co- infections, faring more pronounced than CRP and PCT. Interpretation PTX3 is a promising predictive biomarker for early identification fi cation and risk stratification fi cation of patients with COVID-19 and co-infections. Funding Dolce & Gabbana fashion house donation; Ministero della Salute for COVID-19; EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT) and MUR PNRR Italian network of excellence for advanced diagnosis (Project no. PNC-E3-2022-23683266 PNCHLS-DA); EU MSCA (project CORVOS 860044). Copyright (c) 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Late Breaking Abstract - Co-infections, an unexplored branch in the COVID-19 pandemic
    Gomes, David Noivo
    Alfaiate, Ana
    Clerigo, Vera
    Fernandes, Ligia
    Castanho, Margarida
    Sousa, Susana
    Durao, Vera
    Durao, Fernando
    Duarte, Paula
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis
    Hoque, M. Nazmul
    Akter, Salma
    Mishu, Israt Dilruba
    Islam, M. Rafiul
    Rahman, M. Shaminur
    Akhter, Masuda
    Islam, Israt
    Hasan, Mehedi Mahmudul
    Rahaman, Md Mizanur
    Sultana, Munawar
    Islam, Tofazzal
    Hossain, M. Anwar
    MICROBIAL PATHOGENESIS, 2021, 156
  • [43] Bacterial and Viral Co-Infections in COVID-19 Patients: Etiology and Clinical Impact
    Trifonova, Ivelina
    Madzharova, Iveta
    Korsun, Neli
    Levterova, Viktoria
    Velikov, Petar
    Voleva, Silvya
    Ivanov, Ivan
    Ivanov, Daniel
    Yordanova, Ralitsa
    Tcherveniakova, Tatiana
    Angelova, Svetla
    Christova, Iva
    BIOMEDICINES, 2024, 12 (10)
  • [44] Reply: More unresolved issues about dengue and COVID-19 co-infections
    Hung, Yuan-Pin
    Ko, Wen-Chien
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2025, 124 (01) : 96 - 96
  • [45] Co-infections in Hospitalized COVID-19 Patients-A Prospective Observational Study
    Jalandra, Ramniwas
    Babu, Avinash
    Dutt, Naveen
    Chauhan, Nishant Kumar
    Bhatia, Pradeep
    Nag, Vijaya L.
    Sharma, Praveen
    Kumar, Deepak
    Banerjee, Mithu
    Joshi, Aditi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [46] Co-infections in COVID-19 patients and correlation with mortality rate. Minireview
    FEHER, A. G. N. E. S.
    SZARVAS, Z. S. O. F. I. A.
    LEHOCZK, A. N. D. R. E. A., I
    FEKETE, M. O. N. I. K. A.
    FAZEKAS-PONGOR, V. I. N. C. E.
    PHYSIOLOGY INTERNATIONAL, 2022, 109 (01) : 1 - 8
  • [47] Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study
    Chen, Shuyan
    Zhu, Qing
    Xiao, Yanyu
    Wu, Chi
    Jiang, Zhaofang
    Liu, Lei
    Qu, Jiuxin
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (07): : 815 - 825
  • [48] Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives
    Assandri, Roberto
    Accordino, Silvia
    Canetta, Ciro
    Buscarini, Elisabetta
    Scartabellati, Alessandro
    Tolassi, Chiara
    Serana, Federico
    BIOCHEMIA MEDICA, 2022, 32 (02)
  • [49] Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
    Chhibber-Goel, Jyoti
    Gopinathan, Sreehari
    Sharma, Amit
    GUT PATHOGENS, 2021, 13 (01)
  • [50] Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
    Jyoti Chhibber-Goel
    Sreehari Gopinathan
    Amit Sharma
    Gut Pathogens, 13